glp 1 receptor antagonist examples Evolution of GLP‐1 Agonists for Diabetes Treatment GLP-1 Medications: Everything You Need

95% CI [0.410.95]

Recommended dose: Take 1 capsule daily

Efficacy and safety of aldafermin, an engineered FGF19 analog, in a randomized, double-blind, placebo-controlled trial of patients with nonalcoholic steatohepatitis

The study included data from people with a recent history of obesity and excluded those with diabetes or who have been prescribed another Scientists analyzed the data to see how many people developed one of four gastrointestinal conditions pancreatitis, bowel obstruction, gastroparesis, and Researchers found that the participants who took GLP-1 agonists had a little over nine times higher risk of developing pancreatitis, 4.22 times higher risk of having a bowel obstruction, and 3.67 times increased risk for gastroparesis, compared to people who took We are not entirely surprised [by these results]